IMUNON, INC. (IMNN) SEC News June 29, 2026, 20:21 UTC 1 1 comments Director Lindborg Stacy 🟢 acquired 67.2K shares of Imunon, Inc. (IMNN) at $1.72 Transaction Date: Jun 25, 2026 | Filing ID: 022001 Comment Full text
GAIN THERAPEUTICS, INC. (GANX) SEC News June 29, 2026, 20:21 UTC 1 1 comments (99% Neutral) GAIN THERAPEUTICS, INC. (GANX) Announces Clinical Development Update Comment Full text
CME GROUP INC. (CME) SEC News June 29, 2026, 20:21 UTC 1 1 comments Director Maloney Patrick W 🟢 acquired 645 shares of CME GROUP INC. (CME) at $225.00 Transaction Date: Jun 25, 2026 | Filing ID: 000003 Comment Full text
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) SEC News June 29, 2026, 20:20 UTC 1 1 comments (99% Neutral) BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Announces Regulatory Update Comment Full text
ARTIVA BIOTHERAPEUTICS, INC. (ARTV) SEC News June 29, 2026, 20:20 UTC 1 1 comments RA CAPITAL MANAGEMENT, L.P. 🟢 acquired 32.9K shares of Artiva Biotherapeutics, Inc. (ARTV) at $8.98 Transaction Date: Jun 25, 2026 | Filing ID: 000711 Comment Full text
CELLDEX THERAPEUTICS, INC. (CLDX) SEC News June 29, 2026, 20:20 UTC 1 1 comments Young Diane C. 🟢 acquired 57.0K shares (1 derivative) of Celldex Therapeutics, Inc. (CLDX) at $34.09 ($1.9M) Transaction Date: Jun 25, 2026 | Filing ID: 000002 Comment Full text
CME GROUP INC. (CME) SEC News June 29, 2026, 20:20 UTC 0 1 comments Director Lucas Deborah J 🟢 acquired 645 shares of CME GROUP INC. (CME) at $225.00 Transaction Date: Jun 25, 2026 | Filing ID: 000003 Comment Full text
TARSUS PHARMACEUTICALS, INC. (TARS) SEC News June 29, 2026, 20:19 UTC 0 1 comments (99% Neutral) TARSUS PHARMACEUTICALS, INC. (TARS) Announces Regulatory Update Comment Full text
VTEX (VTEX) SEC News June 29, 2026, 20:19 UTC 0 1 comments do Carmo Thomaz Junior Geraldo 🔴 sold 4.8K shares of VTEX (NYSE: VTEX) at $4.00 Transaction Date: Jun 26, 2026 | Filing ID: 288492 Comment Full text
CELLDEX THERAPEUTICS, INC. (CLDX) SEC News June 29, 2026, 20:19 UTC 0 1 comments Heath-Chiozzi Margo 🟢 acquired 95.0K shares (1 derivative) of Celldex Therapeutics, Inc. (CLDX) at $34.09 ($3.2M) Transaction Date: Jun 25, 2026 | Filing ID: 000002 Comment Full text